Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families-Reference-Cited by-同舟云学术

Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families

Published:2015-11-03 Issue:1 Volume:53 Page:34-42
ISSN:0022-2593
Container-title:Journal of Medical Genetics
language:en
Short-container-title:J Med Genet

Author:

Li Jun,Meeks Huong,Feng Bing-Jian,Healey Sue,Thorne Heather,Makunin Igor,Ellis Jonathan,Campbell Ian,Southey Melissa,Mitchell Gillian,Clouston David,Kirk Judy,Goldgar David,Chenevix-Trench Georgia,

Publisher

BMJ

Subject

Genetics(clinical),Genetics

Reference36 articles.

1. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource;Mann;Breast Cancer Res,2006

2. Gene-panel sequencing and the prediction of breast-cancer risk;Easton;N Engl J Med,2015

3. Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk;Zhang;Tumour Biol,2013

4. Fast and accurate short read alignment with Burrows-Wheeler transform;Li;Bioinformatics,2009

5. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data;McKenna;Genome Res,2010

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline RAD51C and RAD51D Mutations in High-Risk Chinese Breast and/or Ovarian Cancer Patients and Families;Journal of Personalized Medicine;2024-08-16

2. High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands;Breast Cancer;2024-07-13

3. Assessment of genome mutation analysis for tumor-informed detection of circulating tumor DNA in patients with breast cancer;Clinica Chimica Acta;2024-07

4. p53 protein expression patterns associated with TP53 mutations in breast carcinoma;Breast Cancer Research and Treatment;2024-06-20

5. Bayesian meta-analysis of penetrance for cancer risk;Biometrics;2024-03-27